Abbi E. Smith - Concepedia

Author

Abbi E. Smith

Indiana University – Purdue University Indianapolis ORCID

Also Known As

ABBI E. SMITH, Abbi E Smith, Abbi E. Smith, Abbi Elise Smith, Abbi Smith, Donoho, Gregory P, Lajiness, Jacquelyn D, Park, Su-Jung

258

Publications

445

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Indiana University Health Johns Hopkins University University of North Carolina at Chapel Hill

About

Abbi E. Smith is an author at Indiana University – Purdue University Indianapolis specializing in neuro-oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	199
2	Cell Biology	2	2	114
3	Natural Sciences	1	1	41
4	Biology	1	1	41
5	Neurology	1	1	85

Abbi E. Smith

Publications

383

Citations

H-Index

Page 1

	Year	Citations
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Human Molecular Genetics Neuro-oncologyPlexiform NeurofibromaGliomaMedicineMalignant Transformation	2019	90
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Nature Medicine Neuro-oncologyFibrosisPlexiform NeurofibromasNeurofibromatosis Type 1–RelatedPathology	2021	85
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, PLoS ONE	2021	49
Intraspecific cone opsin expression variation in the cichlids of Lake Malawi Adam R. Smith, LINDSAY D’ANNUNZIO, Abbi E. Smith, Molecular Ecology BiologyBiodiversityLake MalawiPhotoreceptor CellMolecular Evolutionary Ecology	2010	41
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours Silpa Gampala, Fenil Shah, Chi Zhang, British Journal of Cancer	2021	25
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2) Eric Hawley, Jeffrey R. Gehlhausen, Sofiia Karchugina, Human Molecular Genetics PathologyCancer BiologyGliomaTumor BiologyNeuro-oncology	2021	24
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression Dana K. Mitchell, Breanne Burgess, Emily E. White, Clinical Cancer Research	2023	21
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma Alyssa C. Flint, Dana K. Mitchell, Steven P. Angus, Clinical Cancer Research	2023	14
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient Mice Ciersten A. Burks, Steven D. Rhodes, Waylan Bessler, Molecular Cancer Therapeutics	2019	12
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17 Julie A. Mund, SuJung Park, Abbi E. Smith, Journal of Biological Chemistry	2020	12

Page 1